Articles tagged with Vasopressors
PCORI awards funding for new patient-centered comparative clinical effectiveness research, addressing key healthcare questions and generating evidence for better-informed decisions. The projects will focus on emergency, hospital, and surgical care, as well as mental and behavioral health, to improve health outcomes.
The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.
Researchers have developed a low-cost fake drug detector that uses an infrared sensor to track pill dissolution rates. The device can identify legitimate medications from counterfeit ones with high accuracy, making it a valuable tool in the fight against global health threats.
Scientists have discovered a novel way to block an enzyme involved in regulating blood pressure, called ACE. Ciprofloxacin binds selectively to a different site, blocking angiotensin I but not inhibiting the enzyme's other functions.
A recent study found that treatment with intravenous acetaminophen for 5 days in critically ill sepsis patients was safe, but did not improve the primary end point of days alive and free of organ support. The study suggests acetaminophen may have a role in preventing or treating organ dysfunction in sepsis.
A clinical trial found that early use of ECMO devices did not improve outcomes for adults with rapidly deteriorating or severe cardiogenic shock. Participants who received immediate ECMO therapy showed similar clinical outcomes as those receiving early conservative therapy, including treatment with inotropes and vasopressors.
Researchers developed a predictive model to guide clinicians in deciding when to give potentially life-saving drugs to ER patients suffering from sepsis. The model analyzes health data and predicts whether patients will need vasopressors within the next few hours, with an accuracy rate of over 80 percent.
A new study found that mechanically ventilated patients treated with vasopressor medications have a higher risk of developing ICU-associated weakness. The use of beta-adrenergic receptor-stimulating vasopressors like norepinephrine was associated with a three-fold increase in the odds of developing weakness.
A recent study by Scott D. Halpern and colleagues found that physicians were more accurate in predicting death but less accurate in predicting cognitive abilities in ICU patients. Nurses' predictions were also variable, with higher accuracy rates for in-hospital mortality and lower accuracy rates for cognition.
A randomized controlled double-blinded trial involving 213 healthy women showed that the DIVA System provided better systolic blood pressure control and reduced nausea incidence compared to manual vasopressor administration. The system's enhanced speed and accuracy deliver a safer and better birth experience for patients.
External cooling in sedated septic shock patients decreases vasopressor requirements and early mortality, increasing the rate of shock reversal and decreasing day-14 mortality. The study's findings suggest that fever control using external cooling is safe and may improve patient outcomes.